{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:27Z","timestamp":1787022207638,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.ppat.1008937","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205100"],"award-info":[{"award-number":["205100"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205100"],"award-info":[{"award-number":["205100"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200187\/Z\/15\/Z"],"award-info":[{"award-number":["200187\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200187\/Z\/15\/Z"],"award-info":[{"award-number":["200187\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200187\/Z\/15\/Z"],"award-info":[{"award-number":["200187\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200187\/Z\/15\/Z"],"award-info":[{"award-number":["200187\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Favipiravir is a nucleoside analogue which has been licensed to treat influenza in the event of a new pandemic. We previously described a favipiravir resistant influenza A virus generated by in vitro passage in presence of drug with two mutations: K229R in PB1, which conferred resistance at a cost to polymerase activity, and P653L in PA, which compensated for the cost of polymerase activity. However, the clinical relevance of these mutations is unclear as the mutations have not been found in natural isolates and it is unknown whether viruses harbouring these mutations would replicate or transmit in vivo. Here, we infected ferrets with a mix of wild type p(H1N1) 2009 and corresponding favipiravir-resistant virus and tested for replication and transmission in the absence of drug. Favipiravir-resistant virus successfully infected ferrets and was transmitted by both contact transmission and respiratory droplet routes. However, sequencing revealed the mutation that conferred resistance, K229R, decreased in frequency over time within ferrets. Modelling revealed that due to a fitness advantage for the PA P653L mutant, reassortment with the wild-type virus to gain wild-type PB1 segment in vivo resulted in the loss of the PB1 resistance mutation K229R. We demonstrated that this fitness advantage of PA P653L in the background of our starting virus A\/England\/195\/2009 was due to a maladapted PA in first wave isolates from the 2009 pandemic. We show there is no fitness advantage of P653L in more recent pH1N1 influenza A viruses. Therefore, whilst favipiravir-resistant virus can transmit in vivo, the likelihood that the resistance mutation is retained in the absence of drug pressure may vary depending on the genetic background of the starting viral strain.<\/jats:p>","DOI":"10.1371\/journal.ppat.1008937","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T16:15:52Z","timestamp":1622564152000},"page":"e1008937","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Favipiravir-resistant influenza A virus shows potential for transmission"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-5963","authenticated-orcid":true,"given":"Daniel H.","family":"Goldhill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-339X","authenticated-orcid":true,"given":"Ada","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-623X","authenticated-orcid":true,"given":"Rebecca","family":"Frise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-2741","authenticated-orcid":true,"given":"Jennifer","family":"Shelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gallego Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-3497","authenticated-orcid":true,"given":"Shahjahan","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola","family":"Akinbami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Galiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8897-7881","authenticated-orcid":true,"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Lackenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"ppat.1008937.ref001","doi-asserted-by":"crossref","first-page":"e26437","DOI":"10.7554\/eLife.26437","article-title":"A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses","volume":"6","author":"MD Pauly","year":"2017","journal-title":"Elife"},{"key":"ppat.1008937.ref002","doi-asserted-by":"crossref","first-page":"e26875","DOI":"10.7554\/eLife.26875","article-title":"Parallel evolution of influenza across multiple spatiotemporal scales","volume":"6","author":"KS Xue","year":"2017","journal-title":"Elife"},{"issue":"1","key":"ppat.1008937.ref003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"VN Petrova","year":"2018","journal-title":"Nature Reviews Microbiology"},{"issue":"9492","key":"ppat.1008937.ref004","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"RA Bright","year":"2005","journal-title":"The Lancet"},{"issue":"5983","key":"ppat.1008937.ref005","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"JD Bloom","year":"2010","journal-title":"Science"},{"issue":"8","key":"ppat.1008937.ref006","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/molbev\/msm103","article-title":"The genesis and spread of reassortment human influenza A\/H3N2 viruses conferring adamantane resistance","volume":"24","author":"L Simonsen","year":"2007","journal-title":"Molecular biology and evolution"},{"issue":"10","key":"ppat.1008937.ref007","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00650-09","article-title":"Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance","volume":"53","author":"Y Furuse","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"18","key":"ppat.1008937.ref008","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"RM Pielak","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"ppat.1008937.ref009","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"S Omoto","year":"2018","journal-title":"Scientific reports"},{"issue":"4","key":"ppat.1008937.ref010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705","volume":"46","author":"Y Furuta","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"ppat.1008937.ref011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Y Furuta","year":"2009","journal-title":"Antiviral Res"},{"issue":"7","key":"ppat.1008937.ref012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Y Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"3","key":"ppat.1008937.ref013","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Y Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ppat.1008937.ref014","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"T Baranovich","year":"2013","journal-title":"J Virol"},{"issue":"2","key":"ppat.1008937.ref015","doi-asserted-by":"crossref","first-page":"e01217","DOI":"10.1128\/JVI.01217-18","article-title":"Determining the mutation bias of favipiravir in influenza virus using next-generation sequencing","volume":"93","author":"DH Goldhill","year":"2019","journal-title":"Journal of virology"},{"issue":"6","key":"ppat.1008937.ref016","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","article-title":"In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses","volume":"54","author":"K Sleeman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"45","key":"ppat.1008937.ref017","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"DH Goldhill","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"20","key":"ppat.1008937.ref018","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1128\/JVI.01226-08","article-title":"Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol","volume":"82","author":"NM Bouvier","year":"2008","journal-title":"Journal of virology"},{"key":"ppat.1008937.ref019","doi-asserted-by":"crossref","first-page":"29793","DOI":"10.1038\/srep29793","article-title":"Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance","volume":"6","author":"R Frise","year":"2016","journal-title":"Scientific Reports"},{"issue":"4","key":"ppat.1008937.ref020","doi-asserted-by":"crossref","first-page":"e1008395","DOI":"10.1371\/journal.ppat.1008395","article-title":"Baloxavir treatment of ferrets infected with influenza A (H1N1) pdm09 virus reduces onward transmission","volume":"16","author":"LYY Lee","year":"2020","journal-title":"PLoS pathogens"},{"issue":"25","key":"ppat.1008937.ref021","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJM198912213212502","article-title":"Emergence and apparent transmission of rimantadine-resistant influenza A virus in families","volume":"321","author":"FG Hayden","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ppat.1008937.ref022","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets","volume":"190","author":"ML Herlocher","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"ppat.1008937.ref023","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States","volume":"301","author":"NJ Dharan","year":"2009","journal-title":"Jama"},{"issue":"21","key":"ppat.1008937.ref024","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.01424-10","article-title":"Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models","volume":"84","author":"CW Seibert","year":"2010","journal-title":"Journal of virology"},{"key":"ppat.1008937.ref025","first-page":"1","article-title":"Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets","author":"M Imai","year":"2019","journal-title":"Nature microbiology"},{"issue":"12","key":"ppat.1008937.ref026","doi-asserted-by":"crossref","first-page":"1900170","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza A (H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019","volume":"24","author":"E Takashita","year":"2019","journal-title":"Eurosurveillance"},{"issue":"3","key":"ppat.1008937.ref027","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3201\/eid1703.101188","article-title":"Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009\u20132010","volume":"17","author":"M Ujike","year":"2011","journal-title":"Emerging infectious diseases"},{"issue":"3","key":"ppat.1008937.ref028","first-page":"346","article-title":"Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza","volume":"221","author":"T Uehara","year":"2020","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ppat.1008937.ref029","doi-asserted-by":"crossref","first-page":"e00230","DOI":"10.1128\/mSphere.00230-18","article-title":"Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Aedes Mosquitoes","volume":"3","author":"L Delang","year":"2018","journal-title":"MSphere"},{"issue":"10","key":"ppat.1008937.ref030","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"L Delang","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ppat.1008937.ref031","doi-asserted-by":"crossref","first-page":"e43303","DOI":"10.1371\/journal.pone.0043303","article-title":"Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret model","volume":"7","author":"KL Roberts","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"ppat.1008937.ref032","doi-asserted-by":"crossref","first-page":"e02063","DOI":"10.1128\/JVI.02063-17","article-title":"Influenza A virus reassortment is limited by anatomical compartmentalization following coinfection via distinct routes","volume":"92","author":"M Richard","year":"2018","journal-title":"Journal of virology"},{"issue":"6","key":"ppat.1008937.ref033","article-title":"Influenza virus reassortment occurs with high frequency in the absence of segment mismatch","volume":"9","author":"LP Nicolle Marshall","year":"2013","journal-title":"PLoS pathogens"},{"issue":"22","key":"ppat.1008937.ref034","doi-asserted-by":"crossref","first-page":"13269","DOI":"10.1128\/JVI.01636-14","article-title":"Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom","volume":"88","author":"RA Elderfield","year":"2014","journal-title":"J Virol"},{"key":"ppat.1008937.ref035","article-title":"Swine ANP32A supports avian influenza virus polymerase","author":"TP Peacock","year":"2020","journal-title":"J. Virol."},{"issue":"5","key":"ppat.1008937.ref036","doi-asserted-by":"crossref","first-page":"e1009527","DOI":"10.1371\/journal.ppat.1009527","article-title":"Evaluating the fitness of PA\/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model","volume":"17","author":"LY Lee","year":"2021","journal-title":"PLoS pathogens"},{"issue":"2","key":"ppat.1008937.ref037","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/jis337","article-title":"Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A (H1N1) pdm09 influenza in Australia","volume":"206","author":"A Hurt","year":"2012","journal-title":"The Journal of infectious diseases"},{"key":"ppat.1008937.ref038","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016\u20132017","volume":"157","author":"A Lackenby","year":"2018","journal-title":"Antiviral research"},{"issue":"1","key":"ppat.1008937.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11428-x","article-title":"Incomplete influenza A virus genomes occur frequently but are readily complemented during localized viral spread","volume":"10","author":"NT Jacobs","year":"2019","journal-title":"Nature communications"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1008937","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T13:46:19Z","timestamp":1623419179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008937"}},"subtitle":[],"editor":[{"given":"Seema","family":"Lakdawala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008937","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.01.277343","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}